Do Patient Navigators Improve Cancer Care Utilization Behaviors? A Meta-Analysis

October 2016 Vol 7, No 9

Categories:

Original Research
Lisa Benz Scott, PhD
Program in Public Health, Stony Brook Medicine, The School of Health Technology & Management Stony Brook University, Stony Brook, Long Island, NY
Tracey J. F., Colella, RN, PhD
Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada, University Health Network/Toronto Rehabilitation, Cardiovascular Prevention & Rehabilitation Program, Toronto, Canada
Naomi Medina-Jaudes
Program in Public Health, Stony Brook Medicine, The School of Health Technology & Management Stony Brook University, Stony Brook, Long Island, NY

Objectives: Patient navigation (PN) interventions are increasingly used in cancer care research and practice with unclear results regarding their effectiveness. Meta-analyses are a powerful tool to determine the effectiveness of interventions. To date, there are no published meta- analyses on PN studies. The purpose of this meta-analysis was to review the empirical evidence regarding PN effects on cancer care–related behavioral outcomes.

Methods: Medline, Embase, HealthSTAR, Cochrane Library, PsycINFO, CINAHL, and Joanna Briggs Institute databases were systematically searched for randomized controlled trials focused on PN (from 1989 to 2015). Two authors screened titles and abstracts and assessed full-text articles based on predefined inclusion/exclusion criteria. One author and 1 research assistant extracted data and conducted quality assessments using the Downs and Black (1998) scoring tool. Analyses were conducted for 3 behavioral outcome categories: performance of recommended health screenings, completion of diagnostic-related behaviors, and attending cancer care follow-up treatment. Effect estimates were pooled using odds ratios, and 95% confidence intervals were calculated through random effects models. The meta-analysis was completed using Review Manager software.

Results: The search identified 3985 articles, of which 20 were included in this analysis focusing on cancer care outcomes. Compared with usual care, patients (n = 13) who received PN interventions were significantly more likely to access cancer screening (OR 2.48; 95% CI, 1.92-3.21; P <.00001). PN was favored to increase adherence to cancer care follow-up treatment (n = 4) and obtaining a cancer diagnoses (n = 3). Most studies involved trained lay navigators (n = 9) compared with health professionals (eg, nurses; n = 7).

Conclusions: This meta-analysis demonstrated that, when compared with usual care, PN interventions are almost 2.5 times more effective in improving the likelihood that individuals will complete recommended cancer screening behaviors and show promise in increasing behaviors leading to diagnostic resolution and completing cancer care follow-up treatment. Although the limitations of this review must be considered, the results suggest that PN is an intervention that can be effective for improving health behavior outcomes in a cancer care context. Future research is warranted to test navigation interventions in a variety of healthcare and commu­nity-based settings.

Related Articles
Efficacy of the Breast Cancer Navigator Role in Reducing Distress in Newly Diagnosed Breast Cancer Patients: A Pilot Study
Patricia Johnson, BS, RN, OCN, CBCN
|
May 2018 Vol 9, No 5
The authors present their findings from a study testing the effects of an early intervention by the Breast Cancer Navigator on distress.
Fear of Cancer Recurrence in Gynecologic Cancer Survivors: An Overview
Annamma Sam, PhD, APRN, WHNP-BC
|
March 2018 Vol 9, No 3
Studies indicate that a high fear of cancer recurrence may be correlated with posttraumatic stress disorder in long-term survivors. A better understanding of this fear in cancer survivors can help clinicians manage this problem effectively.
Evidence-Based Statistics on Complete Prevention and Rapid Sustained Elimination of Chemoradiation Mucositis by High-Potency Polymerized Cross-Linked Sucralfate
Ricky McCullough, MD, MSc
|
February 2018 Vol 9, No 2
This report evaluates the quality of that evidence and provides a plain language review of the statistics regarding the efficacy of High-Potency Polymerized Cross-linked Sucralfate as well as the inherent limitation of some guideline-supported therapies.
Last modified: June 10, 2018

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code